Targeting HIV-1 RNase H:


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
06 07 2020
Historique:
received: 30 04 2020
revised: 28 06 2020
accepted: 01 07 2020
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 23 2 2021
Statut: epublish

Résumé

HIV-1 infection requires life-long treatment and with 2.1 million new infections/year, faces the challenge of an increased rate of transmitted drug-resistant mutations. Therefore, a constant and timely effort is needed to identify new HIV-1 inhibitors active against drug-resistant variants. The ribonuclease H (RNase H) activity of HIV-1 reverse transcriptase (RT) is a very promising target, but to date, still lacks an efficient inhibitor. Here, we characterize the mode of action of

Identifiants

pubmed: 32640577
pii: v12070729
doi: 10.3390/v12070729
pmc: PMC7412550
pii:
doi:

Substances chimiques

Anti-HIV Agents 0
Ribonuclease H EC 3.1.26.4
Ribonuclease H, Human Immunodeficiency Virus EC 3.1.26.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

FEBS J. 2009 Mar;276(6):1482-93
pubmed: 19228197
Nat Protoc. 2008;3(3):427-34
pubmed: 18323814
J Biol Chem. 2002 Jan 11;277(2):1370-4
pubmed: 11684697
DNA Repair (Amst). 2019 Dec;84:102672
pubmed: 31371183
Science. 2020 Feb 7;367(6478):611-612
pubmed: 32029605
Chem Biol Drug Des. 2019 Apr;93(4):582-589
pubmed: 30560566
Nat Protoc. 2011 Jun;6(6):925-33
pubmed: 21637207
Antiviral Res. 2019 Nov;171:104613
pubmed: 31550450
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
Eur J Med Chem. 2018 Aug 5;156:680-691
pubmed: 30031978
Nucleic Acids Res. 2016 Mar 18;44(5):2310-22
pubmed: 26850643
PLoS One. 2016 Jan 22;11(1):e0147225
pubmed: 26800261
JAMA. 2012 Jul 25;308(4):343-4
pubmed: 22820783
Antimicrob Agents Chemother. 2014 Jul;58(7):4086-93
pubmed: 24798282
Curr Med Chem. 2018;25(14):1682-1702
pubmed: 28088905
Nucleic Acids Res. 2003 Dec 1;31(23):6852-9
pubmed: 14627818
J Virol. 2020 Jan 17;94(3):
pubmed: 31694954
Biochemistry. 2002 Apr 16;41(15):4856-65
pubmed: 11939780
Microbiol Spectr. 2014;2(6):1-22
pubmed: 25705574
ACS Med Chem Lett. 2020 Mar 05;11(5):798-805
pubmed: 32435387
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
J Chem Inf Model. 2005 Jan-Feb;45(1):160-9
pubmed: 15667141
Front Microbiol. 2017 Mar 20;8:440
pubmed: 28373864
Mol Pharmacol. 2002 Aug;62(2):398-405
pubmed: 12130693
Eur J Med Chem. 2019 Jan 1;161:1-10
pubmed: 30342421
J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):310-318
pubmed: 31834000
Antimicrob Agents Chemother. 2014 Oct;58(10):6101-10
pubmed: 25092689
J Virol. 2010 Aug;84(15):7625-33
pubmed: 20484498
Eur J Med Chem. 2018 Aug 5;156:652-665
pubmed: 30031976
J Virol. 2010 Sep;84(18):9301-9
pubmed: 20610712
Antiviral Res. 2016 Oct;134:236-243
pubmed: 27659398
Lancet Infect Dis. 2018 Mar;18(3):346-355
pubmed: 29198909
AIDS. 2006 Mar 21;20(5):643-51
pubmed: 16514293
Bioinformatics. 2012 Jun 15;28(12):1647-9
pubmed: 22543367
Antiviral Res. 2005 Feb;65(2):117-24
pubmed: 15708638
Future Med Chem. 2013 Dec;5(18):2127-39
pubmed: 24261890
Mini Rev Med Chem. 2006 Jun;6(6):727-37
pubmed: 16787384
ACS Infect Dis. 2019 Nov 8;5(11):1963-1974
pubmed: 31577424
Curr Pharm Des. 2013;19(10):1850-9
pubmed: 23092286
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28760905
Int J Mol Sci. 2016 Aug 20;17(8):
pubmed: 27556447
Medchemcomm. 2018 Feb 1;9(3):562-575
pubmed: 30108947
J Comput Aided Mol Des. 2006 Dec;20(12):773-88
pubmed: 17051340
Science. 1991 Apr 5;252(5002):88-95
pubmed: 1707186
Antiviral Res. 2015 Nov;123:62-9
pubmed: 26348004
Lancet Infect Dis. 2016 May;16(5):565-575
pubmed: 26831472
J Virol. 2018 May 29;92(12):
pubmed: 29618642
Structure. 2009 Dec 9;17(12):1625-1635
pubmed: 20004166
Nucleic Acids Res. 2003 Jan 1;31(1):298-303
pubmed: 12520007
ChemMedChem. 2016 Aug 19;11(16):1709-20
pubmed: 26990134
Acc Chem Res. 2020 Jan 21;53(1):218-230
pubmed: 31880912
J Virol. 2018 Jun 13;92(13):
pubmed: 29643235
J Infect Dis. 2017 Dec 1;216(suppl_9):S847-S850
pubmed: 29207001

Auteurs

Angela Corona (A)

Department of Life and Environmental Sciences University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy.

Ester Ballana (E)

AIDS Research Institute-IrsiCaixa, 08916 Badalona, Spain.

Simona Distinto (S)

Department of Life and Environmental Sciences University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy.

Dominga Rogolino (D)

Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.

Claudia Del Vecchio (C)

Department of Molecular Medicine, University of Padova, 35122 Padova, Italy.

Mauro Carcelli (M)

Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.

Roger Badia (R)

AIDS Research Institute-IrsiCaixa, 08916 Badalona, Spain.

Eva Riveira-Muñoz (E)

AIDS Research Institute-IrsiCaixa, 08916 Badalona, Spain.

Francesca Esposito (F)

Department of Life and Environmental Sciences University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy.

Cristina Parolin (C)

Department of Molecular Medicine, University of Padova, 35122 Padova, Italy.

José A Esté (JA)

AIDS Research Institute-IrsiCaixa, 08916 Badalona, Spain.
CienciaTraducida, 08391 Barcelona, Spain.

Nicole Grandi (N)

Department of Life and Environmental Sciences University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy.

Enzo Tramontano (E)

Department of Life and Environmental Sciences University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy.
Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche (CNR), 09042 Monserrato, Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH